Brief: NovaBay Pharmaceuticals ISS Supports Co's Proposals To Authorize Sale Of Its Avenova Brand
15/11/2024 13:13
Nov 15 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS: ISS SUPPORTS CO'S PROPOSALS TO
AUTHORIZE SALE OF ITS AVENOVA BRAND
Source text: ID:nBw45WXkqa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing